Thomas G. Ricks's Insider Trades & SAST Disclosures
Thomas G. Ricks's most recent trade in Sensei Biotherapeutics Inc was a trade of 19,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Thomas G. Ricks.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sensei Biotherapeutics Inc | Thomas G. Ricks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
| Ovintiv Inc | Thomas G. Ricks | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2024 | 4,213 | 0 | - | - | Restricted Share Unit | |
| Ovintiv Inc | Thomas G. Ricks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 4,213 | 4,213 | - | - | Restricted Share Unit | |
| Ovintiv Inc | Thomas G. Ricks | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2024 | 4,213 | 94,831 (0%) | 0% | - | Common Stock | |
| Ovintiv Inc | Thomas G. Ricks | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 8,402 | 90,618 (0%) | 0% | - | Common Stock | |
| Ovintiv Inc | Thomas G. Ricks | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 8,402 | 0 | - | - | Restricted Share Unit | |
| Ovintiv Inc | G. Ricks Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 57 | 8,402 | - | - | Restricted Share Unit | |
| Ovintiv Inc | Thomas G. Ricks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2023 | 50 | 8,345 | - | - | Restricted Share Unit | |
| Sensei Biotherapeutics Inc | Thomas G. Ricks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2023 | 14,550 | 14,550 | - | - | Stock Option (Right to Buy) | |
| Sensei Biotherapeutics Inc | Thomas G. Ricks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2023 | 4,466 | 8,932 | - | 0 | Common Stock | |
| Ovintiv Inc | Thomas G. Ricks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 65 | 8,295 | - | - | Restricted Share Unit | |
| Ovintiv Inc | Thomas G. Ricks | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2023 | 6,074 | 82,216 (0%) | 0% | - | Common Stock | |
| Ovintiv Inc | Thomas G. Ricks | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2023 | 6,074 | 8,230 | - | - | Restricted Share Unit | |
| Ovintiv Inc | Thomas G. Ricks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 6,074 | 14,304 | - | - | Restricted Share Unit | |
| Ovintiv Inc | Thomas G. Ricks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 58 | 8,230 | - | - | Restricted Share Unit | |
| Ovintiv Inc | Thomas G. Ricks | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 14,709 | 76,142 (0%) | 0% | - | Common Stock | |
| Ovintiv Inc | Thomas G. Ricks | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 14,709 | 8,172 | - | - | Restricted Share Unit | |
| Ovintiv Inc | Thomas G. Ricks | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 10,000 | 106,269 (0%) | 0% | 0 | Common Stock | |
| Ovintiv Inc | Thomas G. Ricks | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 10,000 | 96,269 (0%) | 0% | 0 | Common Stock | |
| Ovintiv Inc | Thomas G. Ricks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 113 | 22,881 | - | - | Restricted Share Unit | |
| Ovintiv Inc | Thomas G. Ricks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 124 | 22,768 | - | - | Restricted Share Unit | |
| Ovintiv Inc | Thomas G. Ricks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 123 | 22,644 | - | - | Restricted Share Unit | |
| Sensei Biotherapeutics Inc | Thomas G. Ricks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 14,550 | 14,550 | - | - | Stock Option (Right to Buy) | |
| Sensei Biotherapeutics Inc | Thomas G. Ricks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 4,466 | 4,466 | - | 0 | Common Stock | |
| Ovintiv Inc | Thomas G. Ricks | Director | Sale of securities on an exchange or to another person at price $ 59.50 per share. | 07 Jun 2022 | 19,231 | 116,269 (0%) | 0% | 59.5 | 1,144,245 | Common Stock |
| Ovintiv Inc | Thomas G. Ricks | Director | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 23 May 2022 | 10,000 | 135,500 (0%) | 0% | 50 | 500,000 | Common Stock |
| Ovintiv Inc | Thomas G. Ricks | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 4,499 | 22,521 | - | - | Restricted Share Unit | |
| Ovintiv Inc | Thomas G. Ricks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 4,499 | 27,020 | - | - | Restricted Share Unit | |
| Ovintiv Inc | Thomas G. Ricks | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 4,499 | 61,433 (0%) | 0% | - | Common Stock | |
| Ovintiv Inc | Thomas G. Ricks | Director | Sale of securities on an exchange or to another person at price $ 53.73 per share. | 18 Apr 2022 | 10,000 | 145,500 (0%) | 0% | 53.7 | 537,300 | Common Stock |
| Ovintiv Inc | Thomas G. Ricks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 82 | 22,521 | - | - | Restricted Share Unit | |
| Ovintiv Inc | Thomas G. Ricks | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Mar 2022 | 19 | 56,934 (0%) | 0% | - | Common Stock | |
| Ovintiv Inc | Thomas G. Ricks | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 5,184 | 56,915 (0%) | 0% | - | Common Stock | |
| Ovintiv Inc | Thomas G. Ricks | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 5,184 | 22,438 | - | - | Restricted Share Unit | |
| Sensei Biotherapeutics Inc | Thomas G. Ricks | Director | Purchase of securities on an exchange or from another person at price $ 5.86 per share. | 09 Dec 2021 | 20,000 | 341,769 | - | 5.9 | 117,200 | Common Stock |
| Sensei Biotherapeutics Inc | Thomas G. Ricks | Director | Purchase of securities on an exchange or from another person at price $ 6.62 per share. | 09 Dec 2021 | 20,000 | 321,769 | - | 6.6 | 132,400 | Common Stock |
| Ovintiv Inc | Thomas G. Ricks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 7,892 | 27,204 | - | - | Rights (Director Restricted Stock Unit) | |
| Sensei Biotherapeutics Inc | Thomas G. Ricks | Director | 08 Feb 2021 | 11,447,156 | 0 | - | - | Series AA Preferred Convertible Stock | ||
| Sensei Biotherapeutics Inc | Thomas G. Ricks | Director | 08 Feb 2021 | 3,037,849 | 0 | - | - | Series BB Preferred Convertible Stock | ||
| Sensei Biotherapeutics Inc | Thomas G. Ricks | Director | 08 Feb 2021 | 301,769 | 301,769 | - | - | Common Stock | ||
| Sensei Biotherapeutics Inc | Thomas G. Ricks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 16,666 | 16,666 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges